Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Xeris Biopharma Holdings (XERS) Interest Coverage Ratio: 2020-2025

Historic Interest Coverage Ratio for Xeris Biopharma Holdings (XERS) over the last 5 years, with Sep 2025 value amounting to 0.92.

  • Xeris Biopharma Holdings' Interest Coverage Ratio rose 155.78% to 0.92 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.33, marking a year-over-year increase of 121.80%. This contributed to the annual value of -1.10 for FY2024, which is 33.30% up from last year.
  • According to the latest figures from Q3 2025, Xeris Biopharma Holdings' Interest Coverage Ratio is 0.92, which was up 52.24% from 0.61 recorded in Q2 2025.
  • Xeris Biopharma Holdings' 5-year Interest Coverage Ratio high stood at 0.92 for Q3 2025, and its period low was -26.82 during Q4 2021.
  • For the 3-year period, Xeris Biopharma Holdings' Interest Coverage Ratio averaged around -0.92, with its median value being -1.02 (2024).
  • Per our database at Business Quant, Xeris Biopharma Holdings' Interest Coverage Ratio plummeted by 537.75% in 2021 and then soared by 159.18% in 2025.
  • Xeris Biopharma Holdings' Interest Coverage Ratio (Quarterly) stood at -26.82 in 2021, then surged by 87.05% to -3.47 in 2022, then surged by 59.58% to -1.40 in 2023, then surged by 115.53% to 0.22 in 2024, then spiked by 155.78% to 0.92 in 2025.
  • Its Interest Coverage Ratio stands at 0.92 for Q3 2025, versus 0.61 for Q2 2025 and -0.42 for Q1 2025.